Related references
Note: Only part of the references are listed.New benzimidazolequinones as trypanosomicidal agents
Claudia Lopez-Lira et al.
BIOORGANIC CHEMISTRY (2021)
In vitro evaluation of antitrypanosomal activity and molecular docking of benzoylthioureas
Patricia M. L. Pereira et al.
PARASITOLOGY INTERNATIONAL (2021)
Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases
Leandro Rocha Silva et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Quantum computational investigations and molecular docking studies on amentoflavone
Marcia M. Marinho et al.
HELIYON (2021)
Synthesis, activity, and molecular modeling studies of 1,2,3-triazole derivatives from natural phenylpropanoids as new trypanocidal agents
Thiago Belarmino de Souza et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2020)
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review
Ivan Beltran-Hortelano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Selenium as an interesting option for the treatment of Chagas disease: A review
Veronica Alcolea et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling
Alfredo Juarez-Saldivar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Challenges in Chagas Disease Drug Development
Amanda F. Francisco et al.
MOLECULES (2020)
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives
Rocio Paucar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
Julio Alonso-Padilla et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
American Trypanosomiasis (Chagas Disease)
Luis E. Echeverria et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Primary targets of the sesquiterpene lactone deoxymikanolide on Trypanosoma cruzi
Vanesa Puente et al.
PHYTOMEDICINE (2019)
Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach
Lilian Hernandez Alvarez et al.
PLOS ONE (2019)
In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB)
Vinicius Guimaraes da Paixao et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Structure-Based Virtual Screening and In Vitro Evaluation of New Trypanosoma cruzi Cruzain Inhibitors
Veronica Herrera-Mayorga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design
Elany Barbosa da Silva et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2019)
Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain
Lucas Fabian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Novel [1,2,3] triazolo[1,5-a]pyridine derivatives are trypanocidal by sterol biosynthesis pathway alteration
Michel Lapier et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Antichagasic profile of a Series of Mannich Base-Type Derivatives: Design, Synthesis, in vitro Evaluation, and Computational Studies Involving Iron Superoxide Dismutase
Rocio Paucar et al.
CHEMISTRYSELECT (2019)
Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation
Rocio Paucar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity
Marcos Verissimo de Oliveira Cardoso et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'
Glaecia A. N. Pereira et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Trypanocidal Mechanism of Action and in silico Studies of p-Coumaric Acid Derivatives
Susiany P. Lopes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain
Paul D. Boudreau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Natural Sesquiterpene Lactones of the 4,15-iso-Atriplicolide Type are Inhibitors of Trypanothione Reductase
Mairin Lenz et al.
MOLECULES (2019)
Structure-Based and Molecular Modeling Studies for the Discovery of Cyclic Imides as Reversible Cruzain Inhibitors With Potent Anti-Trypanosoma cruzi Activity
Rafael A. A. Ferreira et al.
FRONTIERS IN CHEMISTRY (2019)
Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi
Gleicekelly Silva Coelho et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates
Santiago Royo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors
Lorenzo Cianni et al.
BIOORGANIC CHEMISTRY (2018)
Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma
Raoul De Gasparo et al.
CHEMMEDCHEM (2018)
Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors
Edeildo Ferreira da Silva-Junior et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2018)
Symmetrical and unsymmetrical substituted 2,5-diarylidene cyclohexanones as anti-parasitic compounds
Zia Ud Din et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Investigation of the binding mode of a novel cruzain inhibitor by docking, molecular dynamics, ab initio and MM/PBSA calculations
Luan Carvalho Martins et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)
Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi
Ruben Martin-Escolano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The long road towards a safe and effective treatment of chronic Chagas disease
Julio A. Urbina
LANCET INFECTIOUS DISEASES (2018)
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2018)
CYP51 as drug targets for fungi and protozoan parasites: past, present and future
Galina I. Lepesheva et al.
PARASITOLOGY (2018)
Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors
Debora A. Rocha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Experimental study and computational modelling of cruzain cysteine protease inhibition by dipeptidyl nitriles
Alberto Monteiro Dos Santos et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data
Brenda Vera et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2017)
Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study
Drielli G. Vital et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2017)
Tetradentate polyamines as efficient metallodrugs for Chagas disease treatment in murine model
Francisco Olmo et al.
JOURNAL OF CHEMOTHERAPY (2017)
Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death
Elany Barbosa da Silva et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi
Gevanio Bezerra de Oliveira Filho et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies
Anacleto S. de Souza et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2017)
In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets
Angel H. Romero et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers The STOP-CHAGAS Trial
Carlos A. Morillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Pharmacodynamics and Follow-Up Period in the Treatment of Human Trypanosoma Cruzi Infections With Posaconazole
Julio A. Urbina
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking
Jorge Rodriguez-Becerra et al.
MOLECULAR DIVERSITY (2017)
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors
Karla Fabiola Chacon-Vargas et al.
MOLECULES (2017)
Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
Isidro Palos et al.
MOLECULES (2017)
Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.
Guzman Alvarez et al.
MOLECULES (2017)
Targeting cysteine proteases in trypanosomatid disease drug discovery
Leonardo G. Ferreira et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease
Mario J. Olivera et al.
PLOS ONE (2017)
The effect of specific proline residues on the kinetic stability of the triosephosphate isomerases of two trypanosomes
Valeria Guzman-Luna et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2017)
Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation
Paula Sartor et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
Emir Salas-Sarduy et al.
SCIENTIFIC REPORTS (2017)
Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease
Ivan Beltran-Hortelano et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Prevention of congenital Chagas disease by Benznidazole treatment in reproductive-age women. An observational study
Maria G. Alvarez et al.
ACTA TROPICA (2017)
Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenase
Daniel Ken Inaoka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification
Saulo Fehelberg Pinto Braga et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi
William J. Hoekstra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity
Elena Aguilera et al.
CHEMMEDCHEM (2016)
Current drug therapy and pharmaceutical challenges for Chagas disease
Jose Bermudez et al.
ACTA TROPICA (2016)
Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi
E. F. Silva-Junior et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis and trypanocidal activity of novel benzimidazole derivatives
Jose Miguel Velazquez-Lopez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Challenges in Chagas Disease Drug Discovery: A Review
Rocio Paucar et al.
CURRENT MEDICINAL CHEMISTRY (2016)
New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi
Paulo Andre Teixeira de Moraes Gomes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs
Andressa R. Rettondin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-triazolic bioisosteric analogues
Fredson T. Silva et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi
Francisco Olmo et al.
EXPERIMENTAL PARASITOLOGY (2016)
Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
Abilio Augusto Fragata-Filho et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
The Open Form Inducer Approach for Structure-Based Drug Design
Daniel Ken Inaoka et al.
PLOS ONE (2016)
Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs
Julio A. Urbina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease
Shilpi Khare et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation
Maria V. Papadopoulou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
How an Inhibitor Bound to Subunit Interface Alters Triosephosphate Isomerase Dynamics
Zeynep Kurkcuoglu et al.
BIOPHYSICAL JOURNAL (2015)
The use of posaconazole against Chagas disease
Israel Molina et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2015)
Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits
Karina Martinez-Mayorga et al.
DRUG DISCOVERY TODAY (2015)
Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model
F. Olmo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative
Francisco Olmo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents
Cesar Mendoza-Martinez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo
Guzman Alvarez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Novel 3-Nitrotriazole-Based Amides and Carbinols as Bifunctional Antichagasic Agents
Maria V. Papadopoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity
Lucia Minini et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)
Integrated control of Chagas disease for its elimination as public health problem - A Review
Sergio Sosa-Estani et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
3-H-[1,2] Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies
Marcos Couto et al.
MOLECULES (2015)
Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
Jennifer Riley et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Pharmacophore Modeling for Anti-Chagas Drug Design Using the Fragment Molecular Orbital Method
Ryunosuke Yoshino et al.
PLOS ONE (2015)
New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition
Guzman Alvarez et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Israel Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
R-Configuration of 4-Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi
Jun Yong Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Synthetic single and double aza-scorpiand macrocycles acting as inhibitors of the antioxidant enzymes iron superoxide dismutase and trypanothione reductase in Trypanosoma cruzi with promising results in a murine model
F. Olmo et al.
RSC ADVANCES (2014)
Interactions of antiparasitic sterols with sterol 14α-demethylase (CYP51) of human pathogens
Jasmine Warfield et al.
SPRINGERPLUS (2014)
Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model
Francisco Olmo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Complexes of Trypanosoma cruzi Sterol 14α-Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease STRUCTURAL BASIS FOR PATHOGEN SELECTIVITY
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition
Guzman Alvarez et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Computational study of the mechanism of half-reactions in class 1A dihydroorotate dehydrogenase from Trypanosoma cruzi
Natalia de Farias Silva et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2013)
In Vitro and In Vivo Studies of the Trypanocidal Activity of Four Terpenoid Derivatives against Trypanosoma cruzi
Inmaculada Ramirez-Macias et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Pharmacological Characterization, Structural Studies, and In Vivo Activities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib
Frederick S. Buckner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro and in Vivo Trypanosomicidal Activity of Pyrazole-Containing Macrocyclic and Macrobicyclic Polyamines: Their Action on Acute and Chronic Phases of Chagas Disease
Manuel Sanchez-Moreno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Phthalazine Derivatives Containing Imidazole Rings Behave as Fe-SOD Inhibitors and Show Remarkable Anti-T. cruzi Activity in Immunodeficient-Mouse Mode of Infection
Manuel Sanchez-Moreno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
Shamila S. Gunatilleke et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Recent developments in sterol 14-demethylase inhibitors for Chagas disease
Frederick S. Buckner et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)
Sterol 14alpha-Demethylase (CYP51) as a Therapeutic Target for Human Trypanosomiasis and Leishmaniasis
Galina I. Lepesheva et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
In Vivo Trypanosomicidal Activity of Imidazole- or Pyrazole-Based Benzo[g]phthalazine Derivatives against Acute and Chronic Phases of Chagas Disease
Manuel Sanchez-Moreno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: A problem of residue motility
Antonio Romo-Mancillas et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Blind Dockings of Benzothiazoles to Multiple Receptor Conformations of Triosephosphate Isomerase from Trypanosoma cruzi and Human
Zeynep Kurkcuoglu et al.
MOLECULAR INFORMATICS (2011)
Case Report: Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus
Maria-Jesus Pinazo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Kinetic mechanism and catalysis of Trypanosoma cruzi dihydroorotate dehydrogenase enzyme evaluated by isothermal titration calorimetry
Juliana Cheleski et al.
ANALYTICAL BIOCHEMISTRY (2010)
A Nonazole CYP51 Inhibitor Cures Chagas' Disease in a Mouse Model of Acute Infection
Patricia S. Doyle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase
Norbert Schormann et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Triosephosphate isomerase: a highly evolved biocatalyst
R. K. Wierenga et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery
Juliana Cheleski et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human Pathogen Trypanosoma cruzi
Galina I. Lepesheva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Second Generation Analogues of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery
James M. Kraus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
On the Self-Assembly of a Highly Selective Benzothiazole-Based TIM Inhibitor in Aqueous Solution
Natalia Hassan et al.
LANGMUIR (2010)
Theoretical analysis of intermolecular interactions of selected residues of triosephosphate isomerase from Trypanosoma cruzi with its inhibitor 3-(2-benzothiazolylthio)-1-propanesulfonic acid
Rodrigo Chavez-Calvillo et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2010)
Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme
Shekhar C. Mande et al.
PROTEIN SCIENCE (2010)
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Computational Identification of Uncharacterized Cruzain Binding Sites
Jacob D. Durrant et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate
Olga Senkovich et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Crystallization and preliminary crystallographic studies of dihydrofolate reductase-thymidylate synthase from Trypanosoma cruzi, the Chagas disease pathogen
Penchit Chitnumsub et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2009)
Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose
Juan Gayosso-De-Lucio et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Indomethacin Amides as a Novel Molecular Scaffold for Targeting Trypanosoma cruzi Sterol 14α-Demethylase
Mary E. Konkle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products:: Atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction
Daniel Ken Inaoka et al.
BIOCHEMISTRY (2008)
Efficient inhibition of iron superoxide dismutase and of Trypanosoma cruzi growth by benzo[g]phthalazine derivatives functionalized with one or two imidazole rings
Ana M. Sanz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
CYP51: A Major Drug Target in the Cytochrome P450 Superfamily
Galina I. Lepesheva et al.
LIPIDS (2008)
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development
Antonio Cavazzuti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function
N. Schormann et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Posaconazole: A broad-spectrum triazole antifungal agent
Vijayalakshmi Nagappan et al.
CLINICAL INFECTIOUS DISEASES (2007)
Sterol 14α-demethylase as a potential target for antitrypanosomal therapy:: Enzyme inhibition and parasite cell growth
Galina I. Lepesheva et al.
CHEMISTRY & BIOLOGY (2007)
Perturbation of the Dimer Interface of Triosephosphate Isomerase and its Effect on Trypanosoma cruzi
Vanesa Olivares-Illana et al.
PLOS NEGLECTED TROPICAL DISEASES (2007)
Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine
Rodolfo Viotti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
1,4-bis(alkylamino)benzo[g]phthalazines able to form dinuclear complexes of Cu(II) which as free ligands behave as SOD inhibitors and show efficient in vitro activity against Trypanosoma cruzi
Marinela Rodriguez-Ciria et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment - A nonrandomized trial
Rodolfo Viotti et al.
ANNALS OF INTERNAL MEDICINE (2006)
Genetic diversity and kinetic properties of Trypanosoma cruzi dihydroorotate dehydrogenase isoforms
I Sariego et al.
PARASITOLOGY INTERNATIONAL (2006)
Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor
V Olivares-Illana et al.
BIOCHEMISTRY (2006)
Cyp51 from Trypanosoma cruzi -: A phyla-specific residue in the B′ helix defines substrate preferences of sterol 14α-demethylase
GI Lepesheva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Crystal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitor
N Schormann et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate
DK Inaoka et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2005)
The protein farnesyltransferase inhibitor tipifarnib as a new lead for the development of drugs against Chagas disease
O Hucke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi:: Prospect for chemotherapy of Chagas' disease
O Senkovich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase
S Khabnadideh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Structural considerations for the rational design of selective anti-trypanosomal agents: The role of the aromatic clusters at the interface of triosephosphate isomerase dimer
LM Espinoza-Fonseca et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Inhibitory action of marine algae extracts on the Trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells
T Nara et al.
PARASITOLOGY INTERNATIONAL (2005)
The origin of dihydroorotate dehydrogenase genes of kinetoplastids, with special reference to their biological significance and adaptation to anaerobic, parasitic conditions
T Annoura et al.
JOURNAL OF MOLECULAR EVOLUTION (2005)
A molecular modeling and QSAR study of suppressors of the growth of Trypanosoma cruzi epimastigotes
CHTD da Silva et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)
Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface
A Téllez-Valencia et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design
LM Espinoza-Fonseca et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
2,4-diaminopyrimidines as inhibitors of leishmanial and trypanosomal dihydrofolate reductase
D Pez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi
A Téllez-Valencia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Characterization of the dihydroorotate dehydrogenase as a soluble fumarate reductase in Trypanosoma cruzi
E Takashima et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase
SF Chowdhury et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2002)
Expression, purification, crystallization and preliminary crystallographic analysis of recombinant pteridine reductase of Trypanosoma cruzi
N Schormann et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2001)
Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites
DG Gourley et al.
NATURE STRUCTURAL BIOLOGY (2001)
Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase
F Zuccotto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2001)
A target within the target:: probing Cruzain's P1′ site to define structural determinants for the Chagas' disease protease
LS Brinen et al.
STRUCTURE WITH FOLDING & DESIGN (2000)
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines
MOF Khan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
